Your browser doesn't support javascript.
loading
Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis: A Clinical Trial.
Nichols, David P; Paynter, Alex C; Heltshe, Sonya L; Donaldson, Scott H; Frederick, Carla A; Freedman, Steven D; Gelfond, Daniel; Hoffman, Lucas R; Kelly, Andrea; Narkewicz, Michael R; Pittman, Jessica E; Ratjen, Felix; Rosenfeld, Margaret; Sagel, Scott D; Schwarzenberg, Sarah Jane; Singh, Pradeep K; Solomon, George M; Stalvey, Michael S; Clancy, John P; Kirby, Shannon; Van Dalfsen, Jill M; Kloster, Margaret H; Rowe, Steven M.
Afiliação
  • Nichols DP; Department of Pediatrics, and.
  • Paynter AC; Cystic Fibrosis Foundation Therapeutics Development Network Coordinating Center, Seattle Children's Research Institute, Seattle, Washington.
  • Heltshe SL; Cystic Fibrosis Foundation Therapeutics Development Network Coordinating Center, Seattle Children's Research Institute, Seattle, Washington.
  • Donaldson SH; Department of Pediatrics, and.
  • Frederick CA; Cystic Fibrosis Foundation Therapeutics Development Network Coordinating Center, Seattle Children's Research Institute, Seattle, Washington.
  • Freedman SD; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Gelfond D; Jacobs School of Medicine and Biomedical Sciences of the University of Buffalo, Buffalo, New York.
  • Hoffman LR; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
  • Kelly A; Western New York Pediatric Gastroenterology, Buffalo, New York.
  • Narkewicz MR; Department of Pediatrics, and.
  • Pittman JE; Department of Microbiology, School of Medicine, University of Washington, Seattle, Washington.
  • Ratjen F; Division of Endocrinology and Diabetes, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • Rosenfeld M; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Sagel SD; Digestive Health Institute, Children's Hospital Colorado, Aurora, Colorado.
  • Schwarzenberg SJ; Department of Pediatrics, School of Medicine, University of Colorado, Aurora, Colorado.
  • Singh PK; Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri.
  • Solomon GM; Division of Respiratory Medicine, Department of Pediatrics, Translational Medicine, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
  • Stalvey MS; Department of Pediatrics, and.
  • Clancy JP; Department of Epidemiology, University of Washington School of Medicine, Seattle, Washington.
  • Kirby S; Department of Pediatrics, Children's Hospital Colorado and University of Colorado School of Medicine, Aurora, Colorado.
  • Van Dalfsen JM; Department of Pediatrics, Masonic Children's Hospital, University of Minnesota, Minneapolis, Minnesota.
  • Kloster MH; Department of Microbiology, School of Medicine, University of Washington, Seattle, Washington.
  • Rowe SM; Department of Medicine.
Am J Respir Crit Care Med ; 205(5): 529-539, 2022 03 01.
Article em En | MEDLINE | ID: mdl-34784492
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrose Cística Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Adult / Child / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrose Cística Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Adult / Child / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article